News & Press | Fabric Genomics

News & Press

Study Shows Fabric Genomics’ Algorithm Can Speed Up, Increase Genetic Disease Diagnoses Through Rapid Identification of Structural Variants

April 9, 2021

In a study involving 56 rare genetic disease cases with causal SVs, Fabric GEM – Fabric Genomics’ AI gene-ranking algorithm – provided a unified approach to analyzing SVs and SNVs in a single step, correctly identifying 96 percent of these SVs. Moreover, GEM identified the causal SV in the top five list of all candidates (SVs and SNVs) 93 percent of the time, requiring review of fewer than five candidates per case.

Fabric Genomics Offers Genome Interpretation and Analysis for 46 Patients in Honor of Rare Disease Day

February 25, 2021

Fabric Genomics, a global leader in clinical interpretation of genomic data, announced today an offering of free genome interpretation and analysis for 46 patients with rare disease. Doctors who want to enroll their patients in this program should apply now. Find more information here.

Fabric Genomics to Co-market Comprehensive Sample-to-Genomic Analysis Sequencing Solutions for Hereditary Genetics

October 26, 2020

In a step toward the full realization of genomic medicine, Fabric Genomics, a leader in AI-based genomic analysis and interpretation, has announced a co-marketing agreement that will provide translational researchers around the world with integrated sample prep to reporting workflows. Combining Roche’s newly released KAPA HyperExome Probes (RUO) with the

Fabric Genomics Launches GEM Algorithm to Accelerate Genetic Disease Diagnosis, Provide Comprehensive Clinical-Decision Support

October 21, 2020

Fabric Genomics, a global leader in clinical interpretation of genomic data, announced today the launch of Fabric GEM, a novel algorithm that quickly and efficiently identifies the likely genetic cause of rare diseases from next-generation sequencing data – enabling faster diagnosis and the possibility of faster and more effective treatment.

Watch Now: Applying Artificial Intelligence to Accelerate Variant Classification and Clinical Reporting of NGS Gene Panels

November 20, 2019

Watch the talk by Francisco De La Vega to see how panel testing with Fabric ACE enables clinical labs to perform rapid genomic interpretation to uncover critical insights that reduce costs and save lives.

Fabric Genomics and XIFIN Partner to Expand Access to Clinical Genomics

September 5, 2019

Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a

Fabric Genomics Helps Rady Children’s Institute With the Accelerated Diagnosis of Rare Genetic Diseases

April 24, 2019

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing

Fabric Genomics Announces AI-based ACMG Classification Solution for Genetic Testing with Hereditary Panels

April 2, 2019

Fabric Genomics will launch a new solution this week for variant interpretation and clinical reporting, allowing clinical laboratories to dramatically accelerate turnaround times. This new software solution, called Fabric Hereditary Panels with ACE (AI Classification Engine), will debut at the ACMG annual meeting in Seattle, Washington. The solution incorporates an

ACMG Annual Clinical Genetics Meeting 2019

March 11, 2019

Booth #923 For Meetings, Contact: info@fabricgenomics.com

Diagnomics Introduces ACMG 59 Reports for Personalized Genetic Testing

January 20, 2019

Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and their patients to complement Diagnomics’ portfolio of Personalized Genomics. Diagnomics has partnered with Fabric Genomics to use Fabric Enterprise, its clinical decision-support platform, to generate clinical insights for the report.